Keisuke Kawashima
Papers
1
Total Citations
3
H-Index
1
About
Keisuke Kawashima is a urologic oncologist whose research focuses on improving risk stratification and clinical decision-making for prostate cancer. His work centers on understanding the discrepancies between preoperative needle biopsy findings and final pathology after radical prostatectomy, a critical area for optimizing treatment selection. In his highly cited 2022 study, "Clinical Predictors of Grade Group Upgrading for Radical Prostatectomy Specimens Compared to Those of Preoperative Needle Biopsy Specimens," Kawashima identified key clinical predictors—such as prostate-specific antigen levels and biopsy grade group—that help anticipate upgrading of tumor grade after surgery. This contribution directly addresses a common clinical dilemma, enabling more accurate risk assessment and potentially reducing overtreatment or undertreatment. With over 3 citations already, this work has been recognized as a valuable tool for urologists and oncologists. Kawashima’s research is particularly impactful for students and clinicians seeking to refine prostate cancer management through evidence-based, patient-specific approaches.
Research Focus
Key Achievements
Top Papers
- 1